Compound Detail
CHEMBL5081505
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Basic Information
| ChEMBL ID | CHEMBL5081505 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | WOELGNYRXZQOPS-NOZRDPDXSA-N |
6
Targets
6
Activities
1
Assay Types
0
PK Parameters
11
Publications
0
Known Names
Molecular Properties
419.6
MW (Da)
3.65
ALogP
5
HBA
2
HBD
53.1
PSA (Ų)
0.72
QED
0
Ro5 Violations
7
Rot. Bonds
Drug Information
| Molecule Type | Unknown |
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 6 meas. best 7.46
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Unchecked CHEMBL612545 | IC50 | 7.46 | 7.46 | 35.0 | 1 |
| Alpha-2C adrenergic receptor CHEMBL1916 | IC50 | 5.66 | 5.66 | 2200.0 | 1 |
| Kappa-type opioid receptor CHEMBL237 | IC50 | 5.32 | 5.32 | 4800.0 | 1 |
| Voltage-gated inwardly rectifying potassium channel KCNH2 CHEMBL240 | IC50 | 5.03 | 5.03 | 9300.0 | 1 |
| D(2) dopamine receptor CHEMBL217 | IC50 | 5.01 | 5.01 | 9800.0 | 1 |
| Neuronal acetylcholine receptor subunit alpha-7 CHEMBL2492 | IC50 | 4.77 | 4.77 | 17000.0 | 1 |
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| Unchecked | IC50 | = | 35.0 | nM | 7.46 | Antagonist activity at human CXCR4 receptor expressed in CCRF-CEM cells assessed... | 35179893 |
| Alpha-2C adrenergic receptor | IC50 | = | 2200.0 | nM | 5.66 | Inhibition of alpha 2C adrenergic receptor (unknown origin) | 35179893 |
| Kappa-type opioid receptor | IC50 | = | 4800.0 | nM | 5.32 | Inhibition of kappa opioid receptor (unknown origin) | 35179893 |
| Voltage-gated inwardly rectifying potassium channel KCNH2 | IC50 | = | 9300.0 | nM | 5.03 | Inhibition of human ERG by [3H]]Astemizole binding assay | 35179893 |
| D(2) dopamine receptor | IC50 | = | 9800.0 | nM | 5.01 | Inhibition of dopamine D2 receptor (unknown origin) | 35179893 |
| Neuronal acetylcholine receptor subunit alpha-7 | IC50 | = | 17000.0 | nM | 4.77 | Inhibition of alpha7 nicotinic acetylcholine receptor (unknown origin) | 35179893 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 35179893 | 10.1021/acs.jmedchem.1c01564 | ADMET | 5 |
| 35179893 | 10.1021/acs.jmedchem.1c01564 | Unchecked | 2 |
| 35179893 | 10.1021/acs.jmedchem.1c01564 | Cytochrome P450 2D6 | 1 |
| 35179893 | 10.1021/acs.jmedchem.1c01564 | Alpha-2A adrenergic receptor | 1 |
| 35179893 | 10.1021/acs.jmedchem.1c01564 | Alpha-2C adrenergic receptor | 1 |
| 35179893 | 10.1021/acs.jmedchem.1c01564 | Mu-type opioid receptor | 1 |
| 35179893 | 10.1021/acs.jmedchem.1c01564 | Kappa-type opioid receptor | 1 |
| 35179893 | 10.1021/acs.jmedchem.1c01564 | D(2) dopamine receptor | 1 |
| 35179893 | 10.1021/acs.jmedchem.1c01564 | Muscarinic acetylcholine receptor M2 | 1 |
| 35179893 | 10.1021/acs.jmedchem.1c01564 | Neuronal acetylcholine receptor subunit alpha-7 | 1 |
| 35179893 | 10.1021/acs.jmedchem.1c01564 | Voltage-gated inwardly rectifying potassium channel KCNH2 | 1 |
Data from ChEMBL 36 via Core Engine